Graeme L. Fraser

Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity

Eunyoung Chun, Sydney Lavoie, Diogo Fonseca‐Pereira et al. · Immunity · 2019 · 329 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Evidence for altered synthesis of type II collagen in patients with osteoarthritis.

Fred R.T. Nelson, Leif Dahlberg, Sheila Laverty et al. · Journal of Clinical Investigation · 1998 · 307 citations · Full text

Medicine, Biochemistry, Orthopaedic Surgery +10

Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial

Herman Depypere, D. Timmerman, Gilbert Donders et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 151 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum et al. · Menopause The Journal of The North American Menopause Society · 2020 · 118 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Antihyperalgesic effects of δ opioid agonists in a rat model of chronic inflammation

Graeme L. Fraser, Geneviève‐Anne Gaudreau, Paul B. S. Clarke et al. · British Journal of Pharmacology · 2000 · 111 citations · Full text

Medicine, Neuroscience, Pharmacology +17